A comparison of reimbursement for outpatient intraperitoneal chemotherapy versus intravenous therapy for ovarian cancer

Julian C. Schink*, Catherine M. Hambleton, Emily Berry, Doreine Carson, Tammy Bamlett Sherman, Lisa M. Anastos

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A comparison of reimbursement for outpatient intraperitoneal chemotherapy versus intravenous therapy for ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences